Global Regenerative Medicine Market by End-User Industry and By Application and Forecast
137 Pages Report] The Regenerative Medicine Market is expected to reach USD 38.70 billion, at a CAGR of 23.6%
(firmenpresse) - Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
The major factor driving the growth of this market, our government and private funding to support the development of regenerative medicine, the rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.
The cell-based products are expected to dominate the global Regenerative Medicine market. Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=65442579
The Regenerative Medicine Market research report segmented based on types, therapy, application, and regions.
Based on types, the Regenerative Medicine Market is segmented into cell-based products and acellular products. In 2016, cell-based products expected to dominate the global Regenerative Medicine Market. The key drivers include the increasing awareness about stem cell therapy, growing funding for new stem cell lines, and the development of advanced genomic methods for cell analysis.
Browse and in-depth TOC on
87 Tables
38 Figures
137 Pages
Based on therapy, the Regenerative Medicine Market is segmented into stem cell therapy, tissue regeneration, cell therapy, gene therapy, tissue engineering, and immunotherapy.
The cell therapy segment is expected to account for the largest share of this market, increasing funding from several agencies and private organizations for the research and development of cell therapies, the growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies.
Download PDF ( Regenerative Medicine Research )(at) https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579
By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is expected to account the fastest growing market owing to the increasing prevalence of cancer globally and rich product pipeline and increasing demand for cancer treatments.
Geographical Analysis For Regenerative Medicine Market:
The Global Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in Regenerative medicine and rising incidences of chronic diseases and aging population.
Key players in the Regenerative Medicine Market:
Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).
Themen in dieser Pressemitteilung:
regenerative-cell-therapy
regenerative-therapy
regenerative-medicine
regenerative
tissue-regeneration
steam-cell-therapy
regenerative-steam-cell-therapy
regenrative-medicine-research
regenrative-medicine-journal
regenrative-medicine-market-size
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Datum: 01.02.2019 - 01:50 Uhr
Sprache: Deutsch
News-ID 1546316
Anzahl Zeichen: 3907
contact information:
Contact person: shelly singh
Town:
northbrook
Phone: 18886006441
Kategorie:
Healthcare & Medical
Typ of Press Release: Financial
type of sending: send
Date of sending: 01.02.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 504 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Regenerative Medicine Market by End-User Industry and By Application and Forecast
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
